Carl Dambkowski

Director

Carl Dambkowski (Director) filed 14 Form 4 reports in the trailing twelve months (0 purchases, 14 sales), most often in Apogee Therapeutics, Inc. (APGE). The largest single filing was $6.2M of ORKA (105,000 sh across 3 lots, as filed), executed May 21.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 14 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$18.5M

shares × price, as filed

Last traded

Aug 5

Filed Aug 7

Median ADV $371.2M across their filed names

Open performance→

Volume by month

Buys $0 Sells $20.5M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 14 filings

Sector per market data · by filing · past 12 months

Most traded names

APGE

Apogee Therapeutics, Inc. APGE · 0 buys · 21 sells 21 filings ORKA

Oruka Therapeutics, Inc. ORKA · 0 buys · 2 sells 2 filings

Recent filings

APGESALE Apogee Therapeutics, Inc. View filing → $101K
2,725 sh × $36.96
Exec Jun 4 2025
Filed Jun 6 2025 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. View filing → $143K
3,520 sh × $40.69
Exec Feb 5 2025
Filed Feb 7 2025 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. View filing → $117K
2,486 sh × $47.21
Exec Jan 2 2025
Filed Jan 3 2025 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. View filing → $199K
4,085 sh × $48.62
Exec Dec 11 2024
Filed Dec 13 2024 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. View filing → $307K
6,665 sh × $46.07
Exec Dec 4 2024
Filed Dec 6 2024 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. View filing → $314K
5,326 sh × $58.91
Exec Nov 6 2024
Filed Nov 8 2024 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. View filing → $322K
5,740 sh × $56.16
Exec Oct 2 2024
Filed Oct 4 2024 · 5:30 PM ET